Abstract
In this paper we reported the design, synthesis of a series 2-azetidinones with ester or amide group in C-3 sidechain. Their cholesterol absorption inhibition activity was assessed in orally dosed, cholesterol-fed hamsters. It was demonstrated that compound 20c∼d with amid group in C-3 sidechain exhibited high cholesterol absorption inhibition activity.
Keywords: 2-Azetidinones, C-3 sidechain, Cholesterol absorption inhibition activity
Letters in Drug Design & Discovery
Title: Design and Synthesis of 2-Azetidinone Cholesterol Absorption Inhibitors
Volume: 5 Issue: 1
Author(s): Huibin Zhang, Yubin Wang, Rui Zhao, Wenlong Huang, Yunman Li and Jinpei Zhou
Affiliation:
Keywords: 2-Azetidinones, C-3 sidechain, Cholesterol absorption inhibition activity
Abstract: In this paper we reported the design, synthesis of a series 2-azetidinones with ester or amide group in C-3 sidechain. Their cholesterol absorption inhibition activity was assessed in orally dosed, cholesterol-fed hamsters. It was demonstrated that compound 20c∼d with amid group in C-3 sidechain exhibited high cholesterol absorption inhibition activity.
Export Options
About this article
Cite this article as:
Zhang Huibin, Wang Yubin, Zhao Rui, Huang Wenlong, Li Yunman and Zhou Jinpei, Design and Synthesis of 2-Azetidinone Cholesterol Absorption Inhibitors, Letters in Drug Design & Discovery 2008; 5 (1) . https://dx.doi.org/10.2174/157018008783406741
DOI https://dx.doi.org/10.2174/157018008783406741 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Emerging Role of Vascular Endothelial Growth Factor (VEGF) in Vascular Homeostasis: Lessons from Recent Trials with Anti-VEGF Drugs
Current Vascular Pharmacology Glucocorticoids in Pregnancy
Current Pharmaceutical Biotechnology Stress and Physical Inactivity: Two Explosive Ingredients for the Heart in COVID-19 Pandemic Times
Current Cardiology Reviews Ampelopsin Improves Cognitive Impairment in Alzheimer’s Disease and Effects of Inflammatory Cytokines and Oxidative Stress in the Hippocampus
Current Alzheimer Research Recommendations for the Treatment of Hypertension in Elderly People
Cardiovascular & Hematological Agents in Medicinal Chemistry Progress in the Development of Matrix Metalloproteinase Inhibitors
Current Medicinal Chemistry Change in INSR, APBA2 and IDE Gene Expressions in Brains of Alzheimer's Disease Patients
Current Alzheimer Research Hypoxia Signaling and the Metastatic Phenotype
Current Molecular Medicine Brainstem Neuropeptides and Vagal Protection of the Gastric Mucosal Against Injury: Role of Prostaglandins, Nitric Oxide and Calcitonin-Gene Related Peptide in Capsaicin Afferents
Current Medicinal Chemistry Hypertension in Obstructive Sleep Apnoea
Vascular Disease Prevention (Discontinued) Editorial [Hot Topic: Citokines and Inflammation Markers in Ischemic Stroke (Executive Editor: Antonino Tuttolomondo)]
Current Pharmaceutical Design Glycyrrhizic Acid Ameliorates Cognitive Impairment in a Rat Model of Vascular Dementia Associated with Oxidative Damage and Inhibition of Voltage-Gated Sodium Channels
CNS & Neurological Disorders - Drug Targets Therapeutic Targeting of Endothelial Dysfunction in Chronic Diabetic Complications
Recent Patents on Cardiovascular Drug Discovery Transmembrane Protein 166 and its Significance
Protein & Peptide Letters The Role of Host-Cellular Responses in COVID-19 Endothelial Dysfunction
Current Drug Targets Blood Pressure as a Therapeutic Target in Stroke
Current Topics in Medicinal Chemistry Heuristic Analysis of Genomic Sequence Processing Models for High Efficiency Prediction: A Statistical Perspective
Current Genomics The 100 Most-Cited Papers on Giant Cell Arteritis: A Bibliometric Analysis
Current Rheumatology Reviews Pharmacogenomics in the Intensive Care Unit: Focus on Potential Implications for Clinical Practice
Recent Patents on Biotechnology PCSK9 Inhibitors for the Management of Dyslipidemia in People with Type 2 Diabetes: How Low is Too Low?
Current Pharmaceutical Design